Results 51 to 60 of about 4,241 (120)

Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4[S]

Journal of Lipid Research, 2011
We have used adenovirus-mediated gene transfer in apolipoprotein (apo)E−/− mice to elucidate the molecular etiology of a dominant form of type III hyperlipoproteinemia (HLP) caused by the R142C substitution in apoE4.
Alexander M. Vezeridis, Konstantinos Drosatos, Vassilis I. Zannis   +2 more
doaj   +1 more source

Hydrolysis of Intermediate Density Lipoprotein (IDL) Cholesterol Ester by Carboxyl Esterase and its Role in Lipoprotein Metabolism

The Journal of Japan Atherosclerosis Society, 1989
Kohji SHIRAI, Hiromi KUROSAWA, Yasushi SAITO, Hideyuki HASHIMOTO, Isamu FUKAMACHI, Yoshiaki OHTA, Sho YOSHIDA   +6 more
openaire   +2 more sources

The effect of thiazolidinediones on lipoprotein metabolism: A double blind randomised placebo controlled trial using stable isotopes to investigate the effect of pioglitazone, rosiglitazone and placebo on lipoprotein(apolipoprotein B100, VLDL, IDL and LDL) metabolism.

, 2005
+/- 0.82) with well controlled diabetes (mean HbAlc7.02% +/- 0.15), and lipids (mean total cholesterol 4.91mmol/l +/- 0.17, mean HDL cholesterol 1.21mmol/l +/- 0.06, median triglyceride 1.61 mmol/1 [1.22, 1.97]) at baseline. Following treatment there was a significant reduction in HbAlc in the rosiglitazone (-0.48%, p < 0.05) and the pioglitazone group
openaire   +1 more source

Associations of lipoprotein subclasses with all-cause and cardiovascular mortality: results of two independent cohorts with a 20 year follow-up. [PDF]

Lipids Health Dis
Fierfas F, Bahls M, Henning AK, Petersmann A, Budde K, Dörr M, Völzke H, Nauck M, Hannemann A, Friedrich N.   +9 more
europepmc   +1 more source

Patterns of lipid profile and genetic variations in South Asians. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Rahmanian M.
europepmc   +1 more source

Quantitative 1H-NMR spectroscopy identifies metabolites and lipoprotein subclasses associated with intermediate phenotypes of chronic diseases in the Japanese Nagahama Study. [PDF]

Sci Rep
Ou H, Kawaguchi S, Brial F, Sonomura K, Kawaguchi T, Gravel AE, Das SK, Auld D, Tabara Y, Jean-Claude BJ, Lathrop M, Matsuda F, Gauguier D.   +12 more
europepmc   +1 more source

Distinct Metabolomic and Lipoprotein Signatures in Gall Bladder Cancer Patients of Black African Ancestry. [PDF]

Cancers (Basel)
Devar J, Elebo N, Makan A, Pincus A, Lahoud N, Cacciatore S, Candy G, Smith M, Nweke EE.   +8 more
europepmc   +1 more source

Lipoprotein dynamics in neuromyelitis optica spectrum disorder. [PDF]

J Lipid Res
Liu TW, Cheng ML, Chen CM, Ro LS, Chang KH.   +4 more
europepmc   +1 more source

Alterations of lipoprotein subfractions in GH-deficient adults. [PDF]

Front Endocrinol (Lausanne)
Ratku B, Lőrincz H, Csiha S, Bíró L, Erdei A, Berta E, Ujvárosy D, Bodor M, Nagy EV, Szabó Z, Harangi M, Somodi S.   +11 more
europepmc   +1 more source

A Potential Ratio for Detecting Subclinical Atherosclerosis: Insight into Advanced NMR Lipid Profiles in Severe Obesity. [PDF]

J Cardiovasc Transl Res
Carmona-Maurici J, Eskubi-Turró I, Viñas A, Ricart-Jané D, López-Tejero MD, Amigó N, Bermúdez M, Baena-Fustegueras JA, Peinado-Onsurbe J, Pardina E.   +9 more
europepmc   +1 more source